« Back
Home /
Secukinumab (anti-IL-17A)

Secukinumab (anti-IL-17A)

€960.00

Excl. VAT

Item no.	A2025-5
Manufacturer	Selleckchem
CASRN	1229022-83-6
Amount	1 mg x 5
Category	Neuroscience Neuroinflammation Cell Biology Cell Culture Cytokines Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Cosentyx, AIN457
Available
Description	Secukinumab (anti-IL-17A) (Cosentyx, AIN457) is a human IgG1kappa monoclonal antibody that binds to the protein interleukin (IL)-17A, and is applied for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. MW=147.9 kDa.
Pathway	Immunology & Inflammation
Small Target	Interleukins

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg x 5

Listprice: €960.00

Price: €960.00

available

Delivery expected until 9/4/2025

Quantity:

Compare